- About UNAIDS
- Our work
- Targets and commitments
- 2011 Political Declaration: Targets and elimination commitments
- Reducing sexual transmission
- Preventing HIV among drug users
- Eliminating new HIV infections among children
- 15 million accessing treatment
- Avoiding TB deaths
- Closing the resource gap
- Eliminating gender inequalities
- Eliminating stigma and discrimination
- Eliminating travel restrictions
- Strengthening HIV integration
- 2011 Political Declaration: Targets and elimination commitments
More feature stories on HIV treatment
- UNAIDS welcomes new guidelines which give an additional HIV prevention option to discordant couples
- New guidelines have been issued encouraging couples to go together for HIV testing in order to know their HIV status. The guidelines, released by the World Health Organization (WHO), also recommend that in couples who are serodiscordant—where one partner is living with HIV and the other not—antiretroviral therapy is offered to the person living with HIV to prevent his or her partner from becoming infected with the virus.
- New initiative launched to deliver better, cheaper medicines to Africa
- The need to ensure that people in Africa have access to essential, high quality, safe and affordable medicines has just received a major boost with the launch of the East African Community (EAC) Medicines Registration Harmonization Project in Arusha, Tanzania, on 30 March 2012.
- Zimbabwe: AIDS levy generates new resources for treatment
- An additional 70 000 Zimbabweans living with HIV will get access to anti-retroviral (ARV) treatment by the end of 2012, using the country’s National AIDS Trust Fund. This announcement by the Zimbabwe National AIDS Council is a welcome sign for a country that has some 1.2 million adults and children living with HIV in 2009.
- Libya: UNAIDS works with National Transitional Council to rebuild the country’s AIDS response
- As Libya celebrates the first anniversary of the 17 February revolution, UNAIDS together with the governing National Transitional Council are putting the building blocks for rejuvenate the country’s AIDS response.
- Unparalleled global progress in HIV response but sustained investment vital
- Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term. The latest report by the World Health Organization (WHO), UNICEF and UNAIDS "Report on the Global HIV/AIDS Response" indicates that increased access to HIV services resulted in a 15% reduction of new infections over the past decade and a 22% decline in AIDS-related deaths in the last five years.
- Doha+10: More people accessing HIV treatment
- 10th anniversary of Doha Declaration on TRIPS and Public Health, TRIPS flexibilities improve access to antiretroviral therapy over the past decade.
- Medicines Patent Pool helps make antiretroviral medicines more widely available
- Aurobindo Pharma and MedChem have become the first generic antiretroviral medicines producers to join the Medicines Patent Pool. By joining the Pool, the two manufacturers are able to take advantage of the agreement signed between Gilead Sciences and the Medicines Patent Pool in July 2011.
- Accelerating treatment 2.0 in Asia and the Pacific
- While the number of people living with HIV receiving antiretroviral therapy in Asia and Pacific almost tripled from 280 000 in 2006 to 739 000 in 2009, coverage remains low and only one in three people living with HIV had access to treatment in the region that year. UNAIDS and WHO convened partners to explore the Treatment 2.0 approach during the 10th International Congress on AIDS in Asia and the Pacific.
- Treatment success in South Sudan: Fozia’s story
- In South Sudan, the world’s newest nation, a range of bilateral and multilateral partners have been working with the government to provide HIV prevention, treatment, education and support services to a population recovering from the effects of more than two decades of civil war.
- The Medicines Patent Pool announces negotiations with two additional pharmaceutical companies for patents on HIV medicines
- The Medicines Patent Pool announced that it has begun negotiations with Boehringer-Ingelheim and Bristol-Myers Squibb for patents on HIV medicines essential to treating people living with HIV in the developing world.
- UNAIDS welcomes first voluntary license to the Medicines Patent Pool by a pharmaceutical company
- Medicines Patent Pool sign historic agreement with Gilead Sciences to increase access to HIV medicines in developing countries
- First meeting of BRICS health ministers brings new leadership to global health
- Universal access to medicines was a key topic of discussion at a meeting today of health ministers from Brazil, Russia, India, China and South Africa (BRICS) in Beijing, China.
- India’s Commerce Minister pledges continued availability of high quality generic drugs
- UNAIDS welcomes the assurance given by India’s Commerce Minister, Mr Anand Sharma, that India will reject any efforts to include ‘data exclusivity’ clauses in bilateral trade agreements. This assurance came at a meeting between Mr Sharma and UNAIDS Executive Director Michel Sidibé, held today at the Ministry of Commerce and Industry.
- Applying evidence for results: How can we effectively scale up HIV treatment?
- A special side event was convened for ministers from a wide spectrum of sectors—including health, justice, social development and labour to come together to share their experiences across the new landscape and outlook for HIV treatment, including treatment for prevention.
- World leaders launch plan to eliminate new HIV infections among children by 2015
- World leaders gathered in New York for the 2011 United Nations High Level Meeting on AIDS have today launched a Global Plan that will make significant strides towards eliminating new HIV infections among children by 2015 and keeping their mothers alive.
- HIV treatment: Reducing deaths, illness and HIV infections while keeping costs down
- On the eve of the 2011 General Assembly High Level Meeting on AIDS, a side event on HIV treatment was organized by Médecins Sans Frontières in collaboration with the African Union Permanent Observer Mission to the United Nations.
- Groundbreaking trial results confirm HIV treatment prevents transmission of HIV
- WHO and UNAIDS hail results from the HPTN 052 trial that show antiretroviral therapy to be 96% effective in reducing HIV transmission in couples where one partner has HIV
- Improving access to quality and affordable drugs in Africa: The role of the International Conference on Local Pharmaceutical Production in Africa and the launch of the Southern African Generic Medicines Association
- In developing countries, one of the major challenges for universal access to treatment is access to affordable commodities. Two events in Cape Town are giving an opportunity for discussion, reflection and developing a strategy for improving access to quality and affordable drugs in Africa.
- Treatment 2.0: Translating concept into practice to overcome the HIV epidemic
- How to translate the concept of Treatment 2.0 into practice was the topic of discussion at a seminar organized by UNAIDS’ Evidence, Strategy and Results (ESR) Department.
- South Africa expanding access to ARV therapy
- South African Health Minister Dr Aaron Motsoaledi has announced that South Africa has successfully negotiated a range of price reductions for antiretroviral treatment in a bid to increase access to treatment for people living with HIV.